​

Viatris (VTRS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

VTRS Stock Forecast

Viatris (VTRS) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $15.25, with a high of $18.00 and a low of $12.00. This represents a -3.42% decline from the last price of $15.79.

$10 $11 $12 $13 $14 $15 $16 $17 $18 High: $18 Avg: $15.25 Low: $12 Last Closed Price: $15.79

VTRS Stock Rating

Viatris stock's rating consensus is Hold, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (16.67%), 8 Hold (66.67%), 2 Sell (16.67%), and 0 Strong Sell (0.00%).

Hold
Total 12 0 2 8 2 Strong Sell Sell Hold Buy Strong Buy

VTRS Price Target Upside V Benchmarks

TypeNameUpside
StockViatris-3.42%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks15.31%

Price Target Trends

1M3M12M
# Anlaysts345
Avg Price Target$15.00$15.25$15.20
Last Closing Price$15.79$15.79$15.79
Upside/Downside-5.00%-3.42%-3.74%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26145-111
Jan, 26136-111
Dec, 25-36-110
Nov, 25135-110
Oct, 25125-19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 09, 2026Ashwani VermaUBS$18.00$14.5823.46%14.00%
Jan 28, 2026Piper Sandler$12.00$13.12-8.54%-24.00%
Jan 16, 2026Argus Research$15.00$12.8416.82%-5.00%
Jan 07, 2026Les SulewskiTruist Financial$16.00$12.4029.03%1.33%
Oct 15, 2025Truist Financial$15.00$9.9351.06%-5.00%
Jul 19, 2024Glen SantangeloJefferies$15.00$11.7727.44%-5.00%
Mar 28, 2024David AmsellemPiper Sandler$13.00$11.839.89%-17.67%
Jun 26, 2023David AmsellemPiper Sandler$10.00$9.841.63%-36.67%
Feb 01, 2023Barclays$15.00$12.1623.36%-5.00%
Nov 09, 2022Ashwani VermaUBS$12.00$10.8310.80%-24.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 09, 2026UBSSellBuyupgrade
Jan 28, 2026Piper SandlerNeutralNeutralhold
Dec 08, 2025BarclaysUnderweightOverweightinitialise
Mar 07, 2025JefferiesBuyBuyhold
Mar 05, 2025Piper SandlerNeutralNeutralhold
Mar 28, 2024Piper SandlerNeutralNeutralhold
Jan 12, 2024Cowen & Co.Market Performdowngrade
Dec 27, 2023Morgan StanleyEqual-WeightEqual-Weighthold
Sep 27, 2023Wells FargoEqual-WeightEqual-Weighthold
Jun 26, 2023BMO CapitalPerformMarket Performdowngrade

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 $4 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-1.05$1.71$0.05$-0.53---
Avg Forecast$3.72$3.39$2.96$2.68$2.63$2.69$2.58
High Forecast$3.81$3.42$3.00$2.71$2.75$3.70$2.63
Low Forecast$3.66$3.36$2.90$2.65$2.51$1.57$2.49
Surprise %-128.23%-49.56%-98.31%-119.78%---

Revenue Forecast

$14B $15B $16B $17B $18B $19B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$17.89B$16.26B$15.43B$14.74B---
Avg Forecast$17.89B$16.37B$15.47B$14.81B$14.29B$14.35B$16.56B
High Forecast$18.23B$16.45B$15.53B$14.86B$14.52B$14.38B$16.80B
Low Forecast$17.67B$16.24B$15.42B$14.70B$13.95B$14.32B$16.13B
Surprise %-0.01%-0.67%-0.30%-0.49%---

Net Income Forecast

$-2B $-300M $900M $2B $3B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-1.27B$2.08B$54.70M$-634.20M---
Avg Forecast$-1.13B$66.99M$54.70M$3.24B$3.17B$3.18B$3.09B
High Forecast$-795.14M$309.54M$252.76M$3.27B$3.32B$4.46B$3.17B
Low Forecast$-1.47B$-175.56M$-143.36M$3.20B$3.02B$1.90B$3.01B
Surprise %12.29%3002.87%--119.59%---

VTRS Forecast FAQ

Is Viatris stock a buy?

Viatris stock has a consensus rating of Hold, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 8 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Viatris is a neutral investment for most analysts.

What is Viatris's price target?

Viatris's price target, set by 12 Wall Street analysts, averages $15.25 over the next 12 months. The price target range spans from $12 at the low end to $18 at the high end, suggesting a potential -3.42% change from the previous closing price of $15.79.

How does Viatris stock forecast compare to its benchmarks?

Viatris's stock forecast shows a -3.42% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the specialty & generic drug manufacturers stocks industry (15.31%).

What is the breakdown of analyst ratings for Viatris over the past three months?

  • February 2026: 9.09% Strong Buy, 36.36% Buy, 45.45% Hold, 0% Sell, 9.09% Strong Sell.
  • January 2026: 9.09% Strong Buy, 27.27% Buy, 54.55% Hold, 0% Sell, 9.09% Strong Sell.
  • December 2025: 0% Strong Buy, 30.00% Buy, 60.00% Hold, 0% Sell, 10.00% Strong Sell.

What is Viatris’s EPS forecast?

Viatris's average annual EPS forecast for its fiscal year ending in December 2025 is $2.63, marking a -596.23% decrease from the reported $-0.53 in 2024. Estimates for the following years are $2.69 in 2026, and $2.58 in 2027.

What is Viatris’s revenue forecast?

Viatris's average annual revenue forecast for its fiscal year ending in December 2025 is $14.29B, reflecting a -3.05% decrease from the reported $14.74B in 2024. The forecast for 2026 is $14.35B, and $16.56B for 2027.

What is Viatris’s net income forecast?

Viatris's net income forecast for the fiscal year ending in December 2025 stands at $3.17B, representing a -600.11% decrease from the reported $-634M in 2024. Projections indicate $3.18B in 2026, and $3.09B in 2027.